Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kymera Therapeutics, Inc. | 44,018 | reported | 27 May 2026 | tx 41+569,158−300,537 |
| MADRIGAL PHARMACEUTICALS, INC. | 23,761 | reported | 01 Mar 2010 | tx 6+184,673−4,573 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 May 2026 | SALE | Kymera Therapeutics, Inc. | 3,730 | 78.36 USD | 10b5-1 |
| 26 May 2026 | SALE | Kymera Therapeutics, Inc. | 324 | 79.17 USD | 10b5-1 |
| 26 May 2026 | SALE | Kymera Therapeutics, Inc. | 3,800 | 79.39 USD | 10b5-1 |
| 26 May 2026 | SALE | Kymera Therapeutics, Inc. | 4,500 | 80.02 USD | 10b5-1 |
| 26 May 2026 | SALE | Kymera Therapeutics, Inc. | 551 | 80.71 USD | 10b5-1 |
| 27 May 2026 | SALE | Kymera Therapeutics, Inc. | 3,679 | 81.50 USD | 10b5-1 |
| 27 May 2026 | SALE | Kymera Therapeutics, Inc. | 600 | 82.08 USD | 10b5-1 |
| 25 Mar 2026 | EXERCISE | Kymera Therapeutics, Inc. | 24,727 | 29.64 USD | |
| 25 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 24,727 | 80.26 USD | |
| 23 Mar 2026 | EXERCISE | Kymera Therapeutics, Inc. | 84,400 | 29.64 USD | |
| 23 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 6,105 | 79.87 USD | |
| 23 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 8,214 | 78.40 USD | |
| 23 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 52,975 | 77.21 USD | |
| 23 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 22,756 | 76.73 USD | |
| 23 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 1,200 | 80.05 USD | |
| 23 Mar 2026 | EXERCISE | Kymera Therapeutics, Inc. | 84,400 | 0.00 USD | deriv |
| 25 Mar 2026 | EXERCISE | Kymera Therapeutics, Inc. | 24,727 | 0.00 USD | deriv |
| 11 Mar 2026 | EXERCISE | Kymera Therapeutics, Inc. | 20,000 | 43.50 USD | |
| 11 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 1,765 | 82.13 USD | |
| 11 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 12,882 | 83.10 USD | |
| 11 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 11,111 | 83.72 USD | |
| 11 Mar 2026 | EXERCISE | Kymera Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 04 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 2,017 | 85.04 USD | |
| 02 Mar 2026 | GRANT_AWARD | Kymera Therapeutics, Inc. | 12,575 | 0.00 USD | |
| 04 Mar 2026 | SALE | Kymera Therapeutics, Inc. | 358 | 86.62 USD |